Publications by authors named "Kathrin Fiegl"
Article Synopsis
- The St Jude Medical Trifecta valve is a new type of heart valve for replacing the aortic valve, aimed at improving surgical outcomes for patients with severe valve issues.
- A study involving 837 patients who received the valve showed effective performance, with low pressure gradients, indicating good blood flow, and a high percentage experiencing no patient-prosthesis mismatch.
- While the short-term results are promising with no significant complications reported, further long-term studies comparing it to other valves are necessary to evaluate its effectiveness over time.
Article Synopsis
- The study aimed to assess the long-term performance of the St. Jude Medical Biocor porcine stented bioprosthesis in patients who underwent aortic valve replacement; it involved 455 patients at the German Heart Center Munich from 1985 to 1996.
- The results indicated a 10-year survival rate of 43.3% and a 15-year survival rate of 19.2%, with high freedom from structural valve deterioration (92.1% at 10 years) and low rates of reoperation due to valve-related issues.
- Overall, the research highlights the durability and reliability of the St. Jude Medical Biocor prosthesis over an extended follow-up period, showcasing
Objective The aim of this retrospective study was to evaluate the hemodynamic performance of the St. Jude Medical Trifecta (SJM Trifecta; St. Jude Medical, St Paul, Minnesota, United States) and the Carpentier-Edwards Perimount Magna Ease (CEPM Ease; Edwards Lifesciences, Irvine, California, United States) bioprostheses early postoperative and at 1 year.
View Article and Find Full Text PDF